Summary The prostate gland is said to be immunologically privileged because it lacks afferent lymphatics and because of the immunosuppressive properties of seminal fluid. To elicit the presence or absence of an immune response within the diseased prostate gland, the infiltrate in prostate glands affected by hyperplasia or adenocarcinoma was phenotypically characterised, using immunohistochemical techniques. An infiltrate, composed mainly of T-lymphocytes , was demonstrated in all glands examined. No difference in the type, level of activation or degree of infiltration was found between those glands affected by hyperplasia (n = 20) and those affected by adenocarcinoma (n = 20). In the malignant cases, there was no correlation between grade (Gleason) or stage (TNM) and the type or degree of mononuclear cell infiltrate. Our findings suggest that the host response, in situ, to hyperplasia and adenocarcinoma is similar and may reflect the fact that the two diseases are often found concurrently in the same gland and in close proximity to one another. The infiltrate, therefore, is unlikely to represent a tumour specific immune response to tumour specific antigens. The significant infiltrate we have demonstrated, and its phenotypic characterisation, would not support the hypothesis that the prostate is immunologically privileged as has been suggested previously.
It has been estimated that the majority of men over 60 years will have some degree of prostatic hyperplasia. Likewise, malignant prostatic disease, rare before 50 years, shows a rapidly increasing incidence in the later decades. Latent foci of incidental adenocarcinoma can be found, according to some estimates, in over 40% of prostate glands of men aged 75 years (Halpert & Schmalhorst, 1966) ; most of these fail to cause any morbidity. The prostate is unique in having this very high incidence of occult foci of carcinoma.
The diseased prostate gland, whether affected by hyperplasia or adenocarcinoma, is often noted on routine histological examination to have a variable inflammatory infiltrate. This has usually been assumed in the past, in the absence of relevant bacteriological examination, to be secondary to chronic infection in the prostatic tissue. The presence of an inflammatory infiltrate, however, is well documented in malignant disease involving various organs and is said to represent a host immune response to the tumour (Vose & Moore, 1985) . Recently, the lymphocytic infiltrate in the normal prostate gland has been characterised (El-Demiry et al., 1985) . The infiltrate in the diseased gland, on the other hand, has been poorly characterised (Shaw et al., 1983) and, to the best of our knowledge, the cells within this infiltrate have not been previously examined in situ.
In order to more fully document this mononuclear cell infiltrate we have used cell surface specific monoclonal antibodies to analyse both the type and distribution of these different cell subsets, particularly as regards their relationship to diseased prostatic tissue. In addition, we have used antibodies reactive with the interleukin-2 receptor and HLA-DR antigens to assess the degree of activation of these infiltrating cells.
Materials and methods

Patients
Written consent was obtained from all patients entered in the study.
Prostatic hyperplasia Twenty patients admitted for routine surgery with presumed prostatic hyperplasia were selected. The Prostatic adenocarcinoma Twenty patients with preoperative evidence of adenocarcinoma (i.e. a clinically suspicious gland and/or a biochemical abnormality such as a raised prostatic acid phosphatase and/or prostatic specific antigen) were entered in the study. All patients were clinically staged using the TNM system (Figure 1 ). The mean age was 74 years (range 60-86 years). The two groups were comparable with regard to age with no significant difference between the groups (X2 test, P> 0.5).
Prostatic tissue specimens Fresh tissue was obtained at the time of transurethral prostatic resection. The prostatic chips were snap-frozen and 6-8 gm thick frozen sections were then cut. The sections were allowed to air-dry at room temperature overnight before staining. All sections were stained within 48 h of resection.
All prostatic adenocarcinoma cases were examined by two observers and the degree of differentiation graded using the Gleason grading method (Gleason, 1966 (Gleason, , 1977 . This gave a score (between 2 and 10) and the cases were then placed into three standard grades (grade 1, 2-5; grade 2, 6-7; and grade 3, 8-10) (Figure 1 ).
Monoclonal antibodies
The panel of monoclonal antibodies used is shown in Table  I . The specificities of these antibodies have been well described previously. Figure 2 ) unless they were in the interstitial tissue found between the sheets of tumour cells. From these counts we were able to determine the follow- ing: (i) the relative ratios of T cells, B cells and macrophages in the prostate; (ii) the distribution pattern of the various cells in the two compartments of the gland; and (iii) the ratio of T cell subsets within the prostate.
Results
Prostatic hyperplasia
The 20 cases of hyperplasia showed typical morphology and an inflammatory infiltrate was present in all cases. This ranged from a diffuse infiltrate to intense periglandular collections and was of varying intensity ( Figure 3) . Most of the infiltrating cells were T-lymphocytes (CD-3 +) (Table II) and the majority were found in the periglandular stromal tissue.
Prostatic adenocarcinoma
As with benign disease the main infiltrating cell was the T-lymphocyte (Table II and Figure 4 ). There was no significant difference in the percentages of major cell types found in hyperplasia and adenocarcinoma (P> 0.5, X2). Waldmann, 1986) . Many of these cells also expressed HLA-DR antigen as did a large proportion of the macrophages. The stromal CD-4/CD-8 ratio in hyperplasia and adenocarcinoma was significantly different (P = 0.002, Wilcoxon) but the overall ratio of helper/inducer (CD-4 +) to cytotoxic/suppressor (CD-8 +) cells was similar in both disease processes. There was a significant difference in the subset distribution between the epithelial and stromal com- (Underwood, 1974) and has been postulated to represent a host anti-tumour response (Vose & Moore, 1985; loachim, 1976 (Mostofi & Sesterhenn, 1976; Haskill, 1982) although the converse has been demonstrated (Steele et al., 1984) . Indeed, experimental tumour models have shown that infiltrating host cells can have a tumour promoting effect (Evans, 1978) . The inflammatory infiltrate within the diseased prostate gland has not been previously characterised. The majority of the infiltrating cells were CD-3 positive T-lymphocytes (hyperplasia 69%; adenocarcinoma 63%) with a significant difference in the distribution pattern of the T-lymphocyte subsets between epithelial and stromal tissues. This microanatomical pattern is also seen in normal intestine where the intra-epithelial cells are mainly T-cytotoxic/suppressor cells while the stromal cells are mainly T-helper/inducer cells (Selby et al., 1981; Targan, 1987) . Differences in the infiltrate found in benign and malignant disease have been demonstrated in ovarian and skin neoplasms with significantly fewer T-lymphocytes in benign and borderline epithelial tumours than in their malignant counterparts (Kabawat et al., 1983; Kernohan & Sewell, 1989) . Explanations given for this difference were that it was possibly due to a better recognition of malignant tumours by the immune system or a function of tumour necrosis causing release of chemotactic factors.
Immunological studies in patients with prostatic cancer have shown some evidence of host responses to tumour. This is less prominent than that documented in patients with some other solid tumours. Cell-mediated immunity is depressed in many prostatic cancer patients, but some patients with clinically advanced disease exhibit normal cell-mediated immunity (Catalona, 1980) . This has been postulated to be due to the prostate being a partially immunologically privileged site (Gittes & McCullough, 1974) , the immunosuppressive properties of seminal plasma (Ablin et al., 1980; James & Hargreaves, 1984) and perhaps to tumourelaborated factors (Ablin, 1977) .
The degree of T-lymphocyte activation, as assessed by HLA-DR and IL-2 receptor status, was the same in both benign and malignant prostatic neoplasms. It should be noted that the two disease processes are often concurrent and in close proximity, although the anatomical distribution in the gland has been shown to be different (McNeal, 1969) . The nature of the cellular infiltrate and the level of Tlymphocyte activation demonstrated is not suggestive of an active host response to tumour specific antigens. Nor is it in keeping with the hypothesis that the prostate is in some way an immunologically privileged site. Also our findings suggest that the suppressive effects of seminal plasma in situ may not be profound. Human seminal plasma has been shown to inhibit significantly IL-2R expression on mitogen stimulated peripheral blood T-lymphocytes (Quayle et al., 1987 (1984) .
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